BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10194127)

  • 21. Tumor necrosis factor alpha and lymphotoxin stimulate human myeloblastic leukemia cell (ML-1) invasion through a reconstituted basement membrane (Matrigel) with concomitant induction of 92 kDa gelatinase secretion.
    Kubota S; Takeda K; Yamada T; Nomura Y; Takeda M; Iwamoto S; Seyama Y
    Cancer Lett; 1996 Jan; 98(2):233-40. PubMed ID: 8556714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Overexpression of tissue inhibitor of metalloprotease-2 promotes proliferation and infiltration of human monocytic leukemia cells].
    Li ZJ; Chen ZX; Cen JN; He J
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(34):2409-12. PubMed ID: 17156653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice.
    Nijmeijer BA; Mollevanger P; van Zelderen-Bhola SL; Kluin-Nelemans HC; Willemze R; Falkenburg JH
    Exp Hematol; 2001 Mar; 29(3):322-9. PubMed ID: 11274760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-lineage lymphoid blast crisis in juvenile chronic myelogenous leukemia: II. Interleukin-1-mediated autocrine growth regulation of the lymphoblasts.
    Attias D; Grunberger T; Vanek W; Estrov Z; Cohen A; Lau R; Freedman MH
    Leukemia; 1995 May; 9(5):884-8. PubMed ID: 7769852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth pattern and clinical correlation of subcutaneously inoculated human primary acute leukemias in severe combined immunodeficiency mice.
    Yan Y; Salomon O; McGuirk J; Dennig D; Fernandez J; Jagiello C; Nguyen H; Collins N; Steinherz P; O'Reilly RJ
    Blood; 1996 Oct; 88(8):3137-46. PubMed ID: 8874214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TGF-beta inhibits growth and induces apoptosis in leukemic B cell precursors.
    Buske C; Becker D; Feuring-Buske M; Hannig H; Wulf G; Schäfer C; Hiddemann W; Wörmann B
    Leukemia; 1997 Mar; 11(3):386-92. PubMed ID: 9067578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo anti-leukemic efficacy of anti-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia/lymphoma in mice with severe combined immunodeficiency.
    Gunther R; Chelstrom LM; Finnegan D; Tuel-Ahlgren L; Irvin JD; Myers DE; Uckun FM
    Leukemia; 1993 Feb; 7(2):298-309. PubMed ID: 7678882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production.
    Fusetti L; Pruneri G; Gobbi A; Rabascio C; Carboni N; Peccatori F; Martinelli G; Bertolini F
    Cancer Res; 2000 May; 60(9):2527-34. PubMed ID: 10811135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of tumor necrosis factor (TNF-alpha) in arsenic trioxide induced apoptotic cell death of murine myeloid leukemia cells.
    Mak NK; Wong RN; Leung KN; Fung M
    Toxicol Lett; 2002 Sep; 135(1-2):79-87. PubMed ID: 12243866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of BCL-1 murine B-cell leukemia with recombinant cytokines. Comparative analysis of the anti-leukemic potential of interleukin 1 beta (IL-1 beta), interleukin 2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF alpha), granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), and their combination.
    Chelstrom LM; Finnegan D; Uckun FM
    Leuk Lymphoma; 1992 May; 7(1-2):79-86. PubMed ID: 1282065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of TNF-alpha-induced apoptosis in corneal fibroblasts by transcription factor NF-kappaB.
    Mohan RR; Mohan RR; Kim WJ; Wilson SE
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1327-36. PubMed ID: 10798647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The IL-6 gene expression by leukemic cells from acute lymphoblastic leukemia common and T type and modulation of IL-6 production by TNF.
    Pituch-Noworolska A; Wieckiewicz J; Gawlicka M; Wołoszyn M; Ruggiero I; Zembala M
    Haematologia (Budap); 1998; 29(2):101-14. PubMed ID: 9728802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice.
    Samira S; Ferrand C; Peled A; Nagler A; Tovbin Y; Ben-Hur H; Taylor N; Globerson A; Lapidot T
    Stem Cells; 2004; 22(6):1085-100. PubMed ID: 15536198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL7R is associated with CNS infiltration and relapse in pediatric B-cell precursor acute lymphoblastic leukemia.
    Alsadeq A; Lenk L; Vadakumchery A; Cousins A; Vokuhl C; Khadour A; Vogiatzi F; Seyfried F; Meyer LH; Cario G; Hobeika E; Debatin KM; Halsey C; Schrappe M; Schewe DM; Jumaa H
    Blood; 2018 Oct; 132(15):1614-1617. PubMed ID: 30154115
    [No Abstract]   [Full Text] [Related]  

  • 35. A human acute lymphoblastic leukemia line with the T(4;11) translocation as a model of minimal residual disease in SCID mice.
    Gobbi A; Di Berardino C; Scanziani E; Garofalo A; Rivolta A; Fontana G; Rambaldi A; Giavazzi R; Biondi A
    Leuk Res; 1997; 21(11-12):1107-14. PubMed ID: 9444945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratumoral administration of low doses of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicity.
    Kianmanesh A; Hackett NR; Lee JM; Kikuchi T; Korst RJ; Crystal RG
    Hum Gene Ther; 2001 Nov; 12(17):2035-49. PubMed ID: 11747595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines.
    Kamijo R; Takeda K; Nagumo M; Konno K
    J Immunol; 1990 Feb; 144(4):1311-6. PubMed ID: 2105994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of in vivo tumorigenicity of human lung cancer cells by retrovirus-mediated transfer of the human tumor necrosis factor-alpha cDNA.
    Han SK; Brody SL; Crystal RG
    Am J Respir Cell Mol Biol; 1994 Sep; 11(3):270-8. PubMed ID: 8086165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
    Xun CQ; Thompson JS; Jennings CD; Brown SA
    Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Establishment of human acute B-lymphoblastic leukemia NOD/SCID/IL2 receptor γ chain(null) neonatal mouse xenotransplant model].
    Kong Y; Liu YR; Liu KY; Huang XJ; Ishikawa F; Harada M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):762-8. PubMed ID: 22739198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.